- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Epix and Mallinckrodt expand R&D deal
Contrast agent firms Epix Medical of Cambridge, MA, and Mallinckrodt of St. Louis announced this month an expansion of their existing agreement to research and develop MR imaging technologies. Epix and Mallinckrodt will both fund research in
Contrast agent firms Epix Medical of Cambridge, MA, and Mallinckrodt of St. Louis announced this month an expansion of their existing agreement to research and develop MR imaging technologies. Epix and Mallinckrodt will both fund research in intravascular MRI contrast agents, and they will pursue additional applications for AngioMark, Epixs imaging agent, such as identifying peripheral vascular disease, coronary artery disease, and breast cancer. AngioMark has completed phase II clinical trials for peripheral vascular use, and is in phase II trials for the other two indications. Epix and Mallinckrodt would also like to research the use of AngioMark for macro- and micro-vessel imaging.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
